High Protein Oral Nutritional Support With Special Nutrients in Patients With Type 2 Diabetes and Foot Ulcer
NCT ID: NCT05464407
Last Updated: 2024-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
6 participants
INTERVENTIONAL
2022-02-24
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immunonutrition for Diabetic Foot Ulcers
NCT05281562
Exercise Therapy for People With a Diabetic Foot Ulcer - a Feasibility Study
NCT05101473
Vitamin D Treatment of Diabetic Patients With Foot Ulcers
NCT03813927
The Effect of a Local Injection of a Platelet Concentrate on Infection and Healing of Surgical Wounds
NCT02869204
Evaluation of Personalized Nutritional Intervention on Wound Healing of Cutaneous Ulcers in Diabetics
NCT05243368
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cubitan
2 x oral nutritional supplement daily
Cubitan
2 bottles of Cubitan daily, for 12 weeks.
Usual care
usual care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cubitan
2 bottles of Cubitan daily, for 12 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* accept study participation
Exclusion Criteria
* cognitive challenges, fx dementia
* history with known alcohol or drug abuse
* allergy to milk or soya
* home less
* critical ischemia, distal blood pressure \<0.30
* EGFR \< 30
* dialysis or planned dialysis or patients with terminal kidney insufficiency
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aalborg University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Randi Tobberup
Head of clinical dietitians, Ph.d.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Randi Tobberup, phd
Role: PRINCIPAL_INVESTIGATOR
Aalborg University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aalborg University Hospital
Aalborg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N20210057
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.